Virax Biolabs (VRAX) said Monday it has extended its exclusive distribution agreement with Cosmos Health (COSM) to commercialize Mpox virus test kits in Gulf countries.
Shares of Virax rose more than 38% in recent premarket activity. Cosmos Health added over 6% recently.
Virax had previously signed an exclusive distribution deal for Greece and Cyprus, with a non-exclusive agreement to distribute throughout Europe, the company said. The latest extension covers the Gulf Cooperation Council, including Bahrain, Saudi Arabia and the United Arab Emirates.
Financial details of the contract extension were not disclosed.
Price: 3.5900, Change: +1.00, Percent Change: +38.61
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。